| Year |
Citation |
Score |
| 2013 |
Le Cozannet R, Markou A, Kuczenski R. Extended-access, but not limited-access, methamphetamine self-administration induces behavioral and nucleus accumbens dopamine response changes in rats. The European Journal of Neuroscience. 38: 3487-95. PMID 24112125 DOI: 10.1111/Ejn.12361 |
0.338 |
|
| 2013 |
Laćan G, Hadamitzky M, Kuczenski R, Melega WP. Alterations in the striatal dopamine system during intravenous methamphetamine exposure: Effects of contingent and noncontingent administration Synapse. 67: 476-488. PMID 23417852 DOI: 10.1002/Syn.21654 |
0.341 |
|
| 2012 |
Hadamitzky M, McCunney S, Markou A, Kuczenski R. Development of stereotyped behaviors during prolonged escalation of methamphetamine self-administration in rats. Psychopharmacology. 223: 259-69. PMID 22526541 DOI: 10.1007/S00213-012-2713-1 |
0.356 |
|
| 2010 |
Kuczenski R. Amphetamines Encyclopedia of Neuroscience. 319-323. DOI: 10.1016/B978-008045046-9.01142-6 |
0.333 |
|
| 2009 |
Kuczenski R, Segal DS, Melega WP, Lacan G, McCunney SJ. Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2430-41. PMID 19571794 DOI: 10.1038/Npp.2009.73 |
0.374 |
|
| 2006 |
O'Neil ML, Kuczenski R, Segal DS, Cho AK, Lacan G, Melega WP. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge. Synapse (New York, N.Y.). 60: 465-73. PMID 16897726 DOI: 10.1002/Syn.20320 |
0.368 |
|
| 2006 |
Swerdlow NR, Shoemaker JM, Kuczenski R, Bongiovanni MJ, Neary AC, Tochen LS, Saint Marie RL. Forebrain D1 function and sensorimotor gating in rats: effects of D1 blockade, frontal lesions and dopamine denervation. Neuroscience Letters. 402: 40-5. PMID 16644125 DOI: 10.1016/J.Neulet.2006.03.060 |
0.312 |
|
| 2006 |
Segal DS, Kuczenski R. Human methamphetamine pharmacokinetics simulated in the rat: single daily intravenous administration reveals elements of sensitization and tolerance. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 941-55. PMID 16123749 DOI: 10.1038/Sj.Npp.1300865 |
0.385 |
|
| 2005 |
Segal DS, Kuczenski R, O'Neil ML, Melega WP, Cho AK. Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization. Psychopharmacology. 180: 501-12. PMID 15959831 DOI: 10.1007/S00213-005-2188-4 |
0.407 |
|
| 2005 |
Swerdlow NR, Kuczenski R, Goins JC, Crain SK, Ma LT, Bongiovanni MJ, Shoemaker JM. Neurochemical analysis of rat strain differences in the startle gating-disruptive effects of dopamine agonists. Pharmacology, Biochemistry, and Behavior. 80: 203-11. PMID 15680173 DOI: 10.1016/J.Pbb.2004.11.002 |
0.343 |
|
| 2003 |
Feifel D, Shilling PD, Kuczenski R, Segal DS. Altered extracellular dopamine concentration in the brains of cholecystokinin-A receptor deficient rats. Neuroscience Letters. 348: 147-50. PMID 12932815 DOI: 10.1016/S0304-3940(03)00767-5 |
0.381 |
|
| 2003 |
Segal DS, Kuczenski R, O'Neil ML, Melega WP, Cho AK. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1730-40. PMID 12865898 DOI: 10.1038/Sj.Npp.1300247 |
0.334 |
|
| 2002 |
Kuczenski R, Segal DS. Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 7264-71. PMID 12177221 DOI: 10.1523/Jneurosci.22-16-07264.2002 |
0.352 |
|
| 2002 |
Swerdlow NR, Shoemaker JM, Pitcher L, Platten A, Kuczenski R, Eleey CC, Auerbach P. Genetic differences in startle gating-disruptive effects of apomorphine: evidence for central mediation. Behavioral Neuroscience. 116: 682-90. PMID 12148935 DOI: 10.1037//0735-7044.116.4.682 |
0.311 |
|
| 2001 |
Kuczenski R, Segal DS. Caudate-putamen and nucleus accumbens extracellular acetylcholine responses to methamphetamine binges. Brain Research. 923: 32-8. PMID 11743969 DOI: 10.1016/S0006-8993(01)03193-6 |
0.459 |
|
| 2001 |
Kuczenski R, Segal DS. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. The Journal of Pharmacology and Experimental Therapeutics. 296: 876-83. PMID 11181919 |
0.439 |
|
| 2000 |
Shilling PD, Kelsoe JR, Kuczenski R, Segal DS. Differential regional zif268 messenger RNA expression in an escalating dose/binge model of amphetamine-induced psychosis. Neuroscience. 96: 83-90. PMID 10683413 DOI: 10.1016/S0306-4522(99)00510-2 |
0.311 |
|
| 1999 |
Kuczenski R, Segal DS. Dynamic changes in sensitivity occur during the acute response to cocaine and methylphenidate. Psychopharmacology. 147: 96-103. PMID 10591874 DOI: 10.1007/S002130051147 |
0.468 |
|
| 1999 |
Segal DS, Kuczenski R. Escalating dose-binge treatment with methylphenidate: role of serotonin in the emergent behavioral profile. The Journal of Pharmacology and Experimental Therapeutics. 291: 19-30. PMID 10490882 |
0.511 |
|
| 1999 |
Segal DS, Kuczenski R. Escalating dose-binge stimulant exposure: relationship between emergent behavioral profile and differential caudate-putamen and nucleus accumbens dopamine responses. Psychopharmacology. 142: 182-92. PMID 10102771 DOI: 10.1007/S002130050878 |
0.464 |
|
| 1999 |
Kuczenski R, Segal DS. Sensitization of amphetamine-induced stereotyped behaviors during the acute response: role of D1 and D2 dopamine receptors. Brain Research. 822: 164-74. PMID 10082894 DOI: 10.1016/S0006-8993(99)01149-X |
0.42 |
|
| 1999 |
Cho AK, Melega WP, Kuczenski R, Segal DS, Schmitz DA. Caudate-putamen dopamine and stereotypy response profiles after intravenous and subcutaneous amphetamine. Synapse (New York, N.Y.). 31: 125-33. PMID 10024009 DOI: 10.1002/(Sici)1098-2396(199902)31:2<125::Aid-Syn5>3.0.Co;2-W |
0.458 |
|
| 1999 |
Kuczenski R, Segal DS. Sensitization of amphetamine-induced stereotyped behaviors during the acute response. The Journal of Pharmacology and Experimental Therapeutics. 288: 699-709. PMID 9918578 |
0.504 |
|
| 1997 |
Kuczenski R, Segal DS, Todd PK. Behavioral sensitization and extracellular dopamine responses to amphetamine after various treatments. Psychopharmacology. 134: 221-9. PMID 9438672 DOI: 10.1007/S002130050445 |
0.439 |
|
| 1997 |
Segal DS, Kuczenski R. Behavioral alterations induced by an escalating dose-binge pattern of cocaine administration. Behavioural Brain Research. 88: 251-60. PMID 9404634 DOI: 10.1016/S0166-4328(97)00067-3 |
0.366 |
|
| 1997 |
Kuczenski R, Melega WP, Cho AK, Segal DS. Extracellular dopamine and amphetamine after systemic amphetamine administration: comparison to the behavioral response. The Journal of Pharmacology and Experimental Therapeutics. 282: 591-6. PMID 9262319 |
0.462 |
|
| 1997 |
Segal DS, Kuczenski R. Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization. The Journal of Pharmacology and Experimental Therapeutics. 282: 561-73. PMID 9262316 |
0.444 |
|
| 1997 |
Richtand NM, Kelsoe JR, Kuczenski R, Segal DS. Quantification of dopamine D1 and D2 receptor mRNA levels associated with the development of behavioral sensitization in amphetamine treated rats. Neurochemistry International. 31: 131-7. PMID 9185173 DOI: 10.1016/S0197-0186(96)00097-6 |
0.319 |
|
| 1997 |
Kuczenski R, Segal DS. An escalating dose/multiple high-dose binge pattern of amphetamine administration results in differential changes in the extracellular dopamine response profiles in caudate-putamen and nucleus accumbens. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 4441-7. PMID 9151761 DOI: 10.1523/Jneurosci.17-11-04441.1997 |
0.482 |
|
| 1997 |
Kuczenski R, Segal DS. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. Journal of Neurochemistry. 68: 2032-7. PMID 9109529 DOI: 10.1046/J.1471-4159.1997.68052032.X |
0.498 |
|
| 1997 |
Conti LH, Segal DS, Kuczenski R. Maintenance of amphetamine-induced stereotypy and locomotion requires ongoing dopamine receptor activation. Psychopharmacology. 130: 183-8. PMID 9106917 DOI: 10.1007/S002130050227 |
0.48 |
|
| 1997 |
Segal DS, Kuczenski R. An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 2551-66. PMID 9065515 DOI: 10.1523/Jneurosci.17-07-02551.1997 |
0.427 |
|
| 1996 |
Garcia-Munoz M, Segal DS, Patino P, Young SJ, Kuczenski R, Groves PM. Amphetamine-induced changes in nigrostriatal terminal excitability are modified following repeated amphetamine pretreatment. Brain Research. 720: 131-8. PMID 8782905 DOI: 10.1016/0006-8993(96)00161-8 |
0.381 |
|
| 1996 |
Kuczenski R, Segal D. Behavioral neurotransmitter responses to a “binge” pattern of amphetamine administration European Neuropsychopharmacology. 6: 155. DOI: 10.1016/0924-977X(96)88022-9 |
0.391 |
|
| 1995 |
Kuczenski R, Segal DS, Cho AK, Melega W. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 1308-17. PMID 7869099 DOI: 10.1523/Jneurosci.15-02-01308.1995 |
0.464 |
|
| 1995 |
Segal DS, Kuczenski R, Florin SM. Does dizocilpine (MK-801) selectively block the enhanced responsiveness to repeated amphetamine administration? Behavioral Neuroscience. 109: 532-46. PMID 7662163 DOI: 10.1037//0735-7044.109.3.532 |
0.396 |
|
| 1995 |
Florin SM, Kuczenski R, Segal DS. Effects of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: mechanistic and behavioral considerations. The Journal of Pharmacology and Experimental Therapeutics. 274: 231-41. PMID 7616403 DOI: 10.1038/Sj.Npp.1380146 |
0.47 |
|
| 1994 |
Florin SM, Kuczenski R, Segal DS. Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment. Brain Research. 654: 53-62. PMID 7982098 DOI: 10.1016/0006-8993(94)91570-9 |
0.397 |
|
| 1992 |
Kuczenski R, Segal DS. Regional norepinephrine response to amphetamine using dialysis: comparison with caudate dopamine. Synapse (New York, N.Y.). 11: 164-9. PMID 1626314 DOI: 10.1002/Syn.890110210 |
0.464 |
|
| 1992 |
Segal DS, Kuczenski R. Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Research. 577: 351-5. PMID 1606506 DOI: 10.1016/0006-8993(92)90297-M |
0.455 |
|
| 1992 |
Manley LD, Kuczenski R, Segal DS, Young SJ, Groves PM. Effects of frequency and pattern of medial forebrain bundle stimulation on caudate dialysate dopamine and serotonin. Journal of Neurochemistry. 58: 1491-8. PMID 1548482 DOI: 10.1111/J.1471-4159.1992.Tb11369.X |
0.364 |
|
| 1992 |
Kuczenski R, Segal DS. Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. The Journal of Pharmacology and Experimental Therapeutics. 262: 1085-94. PMID 1527715 |
0.405 |
|
| 1992 |
Florin SM, Kuczenski R, Segal DS. Amphetamine-induced changes in behavior and caudate extracellular acetylcholine. Brain Research. 581: 53-8. PMID 1498671 DOI: 10.1016/0006-8993(92)90343-8 |
0.467 |
|
| 1992 |
Okuda C, Segal DS, Kuczenski R. Deprenyl alters behavior and caudate dopamine through an amphetamine-like action. Pharmacology, Biochemistry, and Behavior. 43: 1075-80. PMID 1475291 DOI: 10.1016/0091-3057(92)90484-W |
0.467 |
|
| 1992 |
Segal DS, Kuczenski R, Okuda C. Clorgyline-induced increases in presynaptic DA: changes in the behavioral and neurochemical effects of amphetamine using in vivo microdialysis. Pharmacology, Biochemistry, and Behavior. 42: 421-9. PMID 1409775 DOI: 10.1016/0091-3057(92)90135-3 |
0.509 |
|
| 1992 |
Segal DS, Kuczenski R. In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment. Brain Research. 571: 330-7. PMID 1377088 DOI: 10.1016/0006-8993(92)90672-V |
0.512 |
|
| 1991 |
Kuczenski R, Segal DS, Aizenstein ML. Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 11: 2703-12. PMID 1715389 DOI: 10.1523/Jneurosci.11-09-02703.1991 |
0.498 |
|
| 1990 |
Kuczenski R, Segal DS, Manley LD. Apomorphine does not alter amphetamine-induced dopamine release measured in striatal dialysates. Journal of Neurochemistry. 54: 1492-9. PMID 2324735 DOI: 10.1111/J.1471-4159.1990.Tb01196.X |
0.42 |
|
| 1990 |
Kuczenski R, Segal DS. In vivo measures of monoamines during amphetamine-induced behaviors in rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 14: S37-50. PMID 2097672 DOI: 10.1016/0278-5846(90)90085-U |
0.507 |
|
| 1990 |
Aizenstein ML, Segal DS, Kuczenski R. Repeated amphetamine and fencamfamine: sensitization and reciprocal cross-sensitization. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 3: 283-90. PMID 1976010 |
0.454 |
|
| 1989 |
Callaway CW, Kuczenski R, Segal DS. Reserpine enhances amphetamine stereotypies without increasing amphetamine-induced changes in striatal dialysate dopamine. Brain Research. 505: 83-90. PMID 2611681 DOI: 10.1016/0006-8993(89)90118-2 |
0.426 |
|
| 1989 |
Kuczenski R, Segal D. Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis Journal of Neuroscience. 9: 2051-2065. PMID 2566664 DOI: 10.1523/Jneurosci.09-06-02051.1989 |
0.443 |
|
| 1989 |
Callaway CW, Segal DS, Kuczenski RT. Amphetamine-induced behavior and dopamine release following reserpine Biological Psychiatry. 25: A47-A48. DOI: 10.1016/0006-3223(89)91582-5 |
0.429 |
|
| 1987 |
Geyer MA, Russo PV, Segal DS, Kuczenski R. Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats. Pharmacology, Biochemistry, and Behavior. 28: 393-9. PMID 3685075 DOI: 10.1016/0091-3057(87)90460-6 |
0.466 |
|
| 1987 |
Segal DS, Kuczenski R. Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates. The Journal of Pharmacology and Experimental Therapeutics. 242: 917-26. PMID 3656119 |
0.441 |
|
| 1987 |
Barnett JV, Segal DS, Kuczenski R. Repeated amphetamine pretreatment alters the responsiveness of striatal dopamine-stimulated adenylate cyclase to amphetamine-induced desensitization. The Journal of Pharmacology and Experimental Therapeutics. 242: 40-7. PMID 2956412 |
0.464 |
|
| 1987 |
Kuczenski R, Segal DS, Leith NJ, Applegate CD. Effects of amphetamine, methylphenidate, and apomorphine on regional brain serotonin and 5-hydroxyindole acetic acid. Psychopharmacology. 93: 329-35. PMID 2448842 DOI: 10.1007/Bf00187252 |
0.386 |
|
| 1986 |
Kuczenski R. Dose response for amphetamine-induced changes in dopamine levels in push-pull perfusates of rat striatum Journal of Neurochemistry. 46: 1605-1611. PMID 3958719 |
0.412 |
|
| 1986 |
Connor CE, Kuczenski R. Evidence that amphetamine and Na+ gradient reversal increase striatal synaptosomal dopamine synthesis through carrier-mediated efflux of dopamine. Biochemical Pharmacology. 35: 3123-30. PMID 3092833 DOI: 10.1016/0006-2952(86)90396-5 |
0.31 |
|
| 1986 |
Barnett JV, Kuczenski R. Desensitization of rat striatal dopamine-stimulated adenylate cyclase after acute amphetamine administration. The Journal of Pharmacology and Experimental Therapeutics. 237: 820-5. PMID 2940359 |
0.385 |
|
| 1986 |
Strait KA, Kuczenski R. Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase Molecular Pharmacology. 29: 561-569. PMID 2872588 |
0.324 |
|
| 1983 |
Kuczenski R, Leith NJ, Applegate CD. Striatal dopamine metabolism in response to apomorphine: the effects of repeated amphetamine pretreatment. Brain Research. 258: 333-7. PMID 6824917 DOI: 10.1016/0006-8993(83)91161-7 |
0.429 |
|
| 1982 |
Kuczenski R, Segal DS, Weinberger SB, Browne RG. Evidence that a behavioral augmentation following repeated amphetamine administration does not involve peripheral mechanisms. Pharmacology, Biochemistry, and Behavior. 17: 547-53. PMID 6890688 DOI: 10.1016/0091-3057(82)90317-3 |
0.404 |
|
| 1982 |
Leith NJ, Kuczenski R. Two dissociable components of behavioral sensitization following repeated amphetamine administration. Psychopharmacology. 76: 310-5. PMID 6812103 DOI: 10.1007/BF00449116 |
0.366 |
|
| 1982 |
Creese I, Kuczenski R, Segal D. Lack of behavioral evidence for dopamine autoreceptor subsensitivity after acute electroconvulsive shock. Pharmacology, Biochemistry, and Behavior. 17: 375-6. PMID 6291070 DOI: 10.1016/0091-3057(82)90096-X |
0.475 |
|
| 1981 |
Kuczenski R, Leith NJ. Chronic amphetamine: is dopamine a link in or a mediator of the development of tolerance and reverse tolerance? Pharmacology, Biochemistry, and Behavior. 15: 405-13. PMID 7291244 DOI: 10.1016/0091-3057(81)90270-7 |
0.446 |
|
| 1980 |
Kuczenski R. Amphetamine-haloperidol interactions on striatal and mesolimbic tyrosine hydroxylase activity and dopamine metabolism Journal of Pharmacology and Experimental Therapeutics. 215: 135-142. PMID 6109012 |
0.378 |
|
| 1979 |
Kuczenski R. Effects of para-chlorophenylalanine on amphetamine and haloperidol-induced changes in striatal dopamine turnover Brain Research. 164: 217-225. PMID 154937 DOI: 10.1016/0006-8993(79)90017-9 |
0.417 |
|
| 1978 |
Kuczenski R. Lack of effect of γ-butyrolactone on amphetamine-induced decrease in striatal synaptosomal dopamine synthesis Journal of Neurochemistry. 31: 347-349. PMID 671029 |
0.366 |
|
| 1977 |
Kuczenski R. Differential effects of reserpine and tetrabenazine on rat striatal synaptosomal dopamine biosynthesis and synaptosomal dopamine pools Journal of Pharmacology and Experimental Therapeutics. 201: 357-367. PMID 870679 |
0.379 |
|
| 1977 |
Kuczenski R. Biphasic effects of amphetamine on striatal dopamine dynamics European Journal of Pharmacology. 46: 249-257. PMID 590334 DOI: 10.1016/0014-2999(77)90340-5 |
0.38 |
|
| 1977 |
Kuczenski R, Schmidt D, Leith N. Amphetamine-haloperidol interactions in rat striatum: Failure to correlate behavioral effects with dopaminergic and cholinergic dynamics Brain Research. 126: 117-129. PMID 558038 DOI: 10.1016/0006-8993(77)90219-0 |
0.431 |
|
| 1976 |
Schmidt D, Kuczenski R. Striatal dopaminergic cholinergic interactions: effect of haloperidol and amphetamine Pharmacologist. 18: No.095. |
0.303 |
|
| 1975 |
Kuczenski R, Segal DS. Differential effects of D- and L-amphetamine and methylphenidate on rat striatal dopamine biosynthesis. European Journal of Pharmacology. 30: 244-51. PMID 1126362 DOI: 10.1016/0014-2999(75)90106-5 |
0.397 |
|
| 1975 |
Kuczenski R. Conformational adaptability of tyrosine hydroxylase in the regulation of striatal dopamine biosynthesis Advances in Biochemical Psychopharmacology. 13: 109-125. PMID 239530 |
0.326 |
|
| 1975 |
Kuczenski R. Effects of catecholamine releasing agents on synaptosomal dopamine biosynthesis: Multiple pools of dopamine or multiple forms of tyrosine hydroxylase? Neuropharmacology. 14: 1-10. PMID 239360 DOI: 10.1016/0028-3908(75)90060-X |
0.369 |
|
| 1972 |
Mandell AJ, Knapp S, Kuczenski RT, Segal DS. Methamphetamine-induced alteration in the physical state of rat caudate tyrosine hydroxylase. Biochemical Pharmacology. 21: 2737-50. PMID 4405233 DOI: 10.1016/0006-2952(72)90022-6 |
0.317 |
|
| 1971 |
Segal DS, Sullivan JL, Kuczenski RT, Mandell AJ. Effects of long-term reserpine treatment on brain tyrosine hydroxylase and behavioral activity. Science (New York, N.Y.). 173: 847-9. PMID 5572177 DOI: 10.1126/Science.173.3999.847 |
0.312 |
|
| Show low-probability matches. |